Orchid Pharma Limited Press Release Jul 07 2026
Filed with NSE · · 3 pages · English
Subject: Announcement under Regulation 30 regarding the licensing and supply agreement with Pharmasyntez JSC, Russia Kapil Dayya Company Secretary & Compliance Officer Encl: As Above 7th July 2026 Orchid Pharma Signs Licensing and Supply Agreement with Pharmasyntez to Commercialize Exblifep® (Cefepime/Enmetazobactam) in Russia Orchid Pharma Ltd. (Orchid) and Pharmasyntez JSC (Pharmasyntez) have en
Earlier from Orchid Pharma
- Orchid Launches Identity Audit to Illuminate the Dark Matter of Enterprise Identity Activity
- Tecomet and Orchid Orthopedic Solutions to Merge
- Orchid Security named a Cool Vendor in the 2025 Gartner® Cool Vendors™ in Identity-First Security
- Orchid Accelerates Identity Governance by Letting Applications Speak for Themselves
- Press Release Feb 19 2025
Later from Orchid Pharma
All Orchid Pharma news releasesFollow Orchid Pharma into a list and get an email when it puts out news.
Follow Orchid Pharma